|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.1 NOK | -0.90% |
|
+1.53% | -9.81% |
| 05-06 | Navamedic Rolls Out Erectile Dysfunction Drug in Sweden | MT |
| 04-30 | Navamedic ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Navamedic ASA reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was NOK 382.14 million compared to NOK 278.44 million a year ago. Revenue was NOK 382.14 million compared to NOK 278.44 million a year ago.
Net income was NOK 29.43 million compared to NOK 0.618 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -9.81% | 53.2M | |
| +30.38% | 684B | |
| +26.51% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.70% | 240B | |
| +8.78% | 208B | |
| -7.93% | 200B | |
| +7.68% | 166B |
NAVAMEDIC ASA 
